Inari Medical (NASDAQ:NARI) Stock, Quote.Headers.trade-ideas

Inari Medical

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

NARI

News

Health Care

General

The FDA labels Inari Medical&#39;s ClotTriever catheter recall as the most serious, citing risks like device entrapment and pulmonary emboli, linked to injuries and deaths.

FDA Classifies Recall Of Inari Medical&#39;s Large Vessel Clot Removal Catheter Device As Most Serious

Earnings

Earnings Misses

Guidance

Markets

Analyst Ratings

Trading Ideas

HOLX

Inari Medical, Inc. (NASDAQ: NARI) reported an adjusted loss per share of 41 cents in the second quarter of 2024 compared with the year-ago period&#39;s loss of 4 cents per share. The Zacks Consensus Estimate for loss per share was pegged at 16 cents.

Inari Medical Q2 Earnings Miss, Revenues Increase Y/Y

ALGN

Inari Medical (NASDAQ: NARI) continues to ride on the success of its ClotTriever and FlowTriever products available for treating venous thromboembolism (VTE).

Inari&#39;s Expanding Product Portfolio Offsets Competition

Inari Medical Inc

Chinese electric vehicle manufacturer BYD (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rival plans to establish its <a href="https://www.benzinga.com/markets/equities/24/09/40946478/chinas-nio-says-40-of-its-store-managers-are-ex-tesla">first South Asian assembly plant in Pakistan</a>. The move follows a rejection from India.
What Happened: The plant, expected to be operational by 2026, is a collaboration with Pakistan&#8217;s largest private electricity producer, Hub Power (Hubco). Hubco&#8217;s subsidiary, Mega Motor, will partner with BYD to set up the facility near Karachi's Port Qasim, <a href="https://www.ft.com/content/bf1e6817-5313-4b6e-8e47-9e2960d30ecc">reported</a> Financial Times on Sunday. 
Hubco CEO Kamran Kamal said that the goal is for Pakistan to begin exporting vehicles from the plant. The government is encouraging BYD to target markets in Africa and South Asia, including Bangladesh and Sri Lanka.
"We have big ambitions to be the leading carmaker in this country by the end of the decade," Kamal said. "For any industry in Pakistan to be competitive, they should be focused on the export market."
BYD&#8217;s expansion into Pakistan comes amid broader international growth, with new factories planned in Turkey, Hungary, Thailand, and Brazil. The company is also considering a new factory in Mexico.
BYD declined to comment further on the specifics of the Pakistan project, which is still under discussion. The company aims to sell 100,000 plug-in hybrid and fully electric cars annually in Pakistan by 2030, according to the report.
See Also: <a href="https://www.benzinga.com/news/24/09/40899599/elon-musk-said-spacex-competitors-only-take-up-less-than-we-do-and-they-take-nothing-down-and-they-g?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Said SpaceX Competitors Only &#8216;Take Up Less Than We Do, And They Take Nothing Down, And They Get Paid Twice As Much&#8217; — 10 Years Later, Its Rival In Space Boeing Has Frozen Hiring And Is Weighing Furloughs</a>
Why It Matters: The decision by BYD to establish a plant in Pakistan follows a series of global strategic moves by Chinese automakers to counteract increasing trade barriers and tariffs. 
Recently, the President Joe Biden administration imposed <a href="https://www.benzinga.com/markets/asia/24/09/40886450/50-of-new-car-sales-in-china-are-electric-but-in-the-us-its-only-10-are-protectionist-policies-widen">a 100% tax on electric vehicles made in China</a>, affecting companies like BYD and Geely. This move is part of a broader effort to relocate manufacturing and boost U.S. jobs.
China has also advised its automakers to keep advanced EV technology within the country, even as they expand globally. This includes exporting knock-down kits for assembly abroad, and ensuring <a href="https://www.benzinga.com/news/24/09/40825946/china-wants-automakers-to-safeguard-their-ev-technology-and-keep-it-within-the-country-as-companies">key parts remain produced in China</a>.
BYD&#8217;s expansion is not just limited to Pakistan. The company has been making significant strides in Europe, showcasing their vehicles at trade fairs like the Automechanika in Frankfurt, <a href="https://www.benzinga.com/markets/equities/24/09/40818732/chinese-ev-manufacturers-byd-and-geely-storm-frankfurt-fair-as-eu-tariffs-threaten-to-crimp-thei">despite looming EU tariffs</a>.
Furthermore, the competitive <a href="https://www.benzinga.com/markets/equities/24/09/40946478/chinas-nio-says-40-of-its-store-managers-are-ex-tesla">landscape in China is intensifying</a>. Companies like NIO are also expanding aggressively, with a significant portion of their management coming from Tesla.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40968088/teslas-stock-performance-in-2019-and-2024-shows-striking-similarities-says-gary-bla?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Stock Performance In 2019 And 2024 Shows &#8216;Striking&#8217; Similarities, Says Gary Black: Flags This Reason That May Lead To Price Surge In 2025</a></li>
</ul>
Image Via Shutterstock 
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Equities

BYDDF

BYDDY

TSLA

Tesla's Chinese Rival BYD Plans To Assemble EVs In Pakistan After India Said No: 'We Have Big Ambitions'

NBA legend Shaquille O&#8217;Neal has been falsely accused of ejecting Governor Tim Walz&nbsp;(D-Minn), the running mate of Democratic presidential nominee Kamala Harris, from his restaurant.
What Happened: Earlier this month, a Facebook post from an account named &#8220;WNBA News Daily,&#8221; falsely shared a post stating that Shaq, had thrown out Walz from his restaurant in Georgia.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/22224204/Screenshot-2024-09-23-at-8.11.49%E2%80%AFAM-878x1024.png" alt="" class="wp-image-560144" /></figure>
This false story was shared by many other people on social media platforms too including one by Vernon Jones, a former state representative from Georgia.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/22224217/Screenshot-2024-09-23-at-8.10.36%E2%80%AFAM-1024x678.png" alt="" class="wp-image-560145" /></figure>
However, lo and behold, this entire incident was written by a satirical website.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/09/40968413/elon-musk-reacts-after-cathie-wood-labels-gavin-newsoms-threat-to-sue-tesla-ceo-over-memes-unconstit?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts After Cathie Wood Labels Gavin Newsom&#8217;s Threat To Sue Tesla CEO Over Memes &#8216;Unconstitutional&#8217;: &#8216;…But That Didn&#8217;t Stop Them&#8217;</a>
The original article was published on &#8220;Esspots,&#8221; a self-proclaimed &#8220;one-stop&nbsp;destination for satirical news and&nbsp;commentary about the United States&nbsp;of America.&#8221;
&#8220;Our team of writers and editors is dedicated to bringing you the latest and greatest in fake news and absurdity, all with a healthy dose of humor and satire,&#8221; the website states in the &#8220;About Us&#8221; section.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/22224639/Screenshot-2024-09-23-at-8.16.27%E2%80%AFAM-1024x653.png" alt="" class="wp-image-560150" /></figure>
Shaq&#8217;s restaurant chain, Big Chicken, does not have a location in Georgia, according to Big Chicken&#8217;s official website.
This fact check was first <a href="https://factcheck.afp.com/about-afp">done</a> by AFP Fact Check, a department within&nbsp;Agence France-Presse, which also noted that campaign schedules for the candidates did not mention any planned visit by Walz&nbsp;to a Big Chicken outlet.
Why It Matters: Walz has been a target&nbsp;of misinformation since joining the&nbsp;Democratic ticket. This incident serves as another example of misleading claims circulating on social media.
Earlier, a false claim that Harris was involved in a 2011 hit-and-run accident in San Francisco, which allegedly paralyzed a 13-year-old girl, circulated widely on social media platforms.
This incident also comes amid a <a href="https://www.benzinga.com/general/entertainment/24/09/40807445/taylor-swift-says-i-will-be-casting-my-vote-for-kamala-harris-and-tim-walz-takes-a-dig-at-j">politically charged climate</a>, with celebrities like&nbsp;Taylor Swift&nbsp;publicly endorsing Vice President Kamala Harris and Walz for the 2024 presidential race.
Meanwhile, Shaq has previously revealed that he voted for the first time at the age of 48 in 2020. The retired NBA star supported President Joe Biden in the presidential election that year, <a href="https://thehill.com/homenews/campaign/560538-shaq-endorses-candidate-in-race-for-demings-house-seat/">according</a> to The Hill.
Image via Flickr/ Cubahora
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40958452/mark-cuban-says-elon-musk-believes-hes-much-smarter-than-trump-reveals-the-intoxicating-reason-why-t?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Says Elon Musk &#8216;Believes He&#8217;s Much Smarter Than Trump,&#8217; Reveals The &#8216;Intoxicating&#8217; Reason Why Tesla CEO Supports Ex-President</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Social Media

Politics

NBA Star Shaquille O'Neal Threw Tim Walz Out From His Big Chicken Restaurant And Said, 'Don't Come Back' — Fact Or Fiction

Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) and Samsung Electronics Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) are discussing the construction of massive chip-making complexes in the United Arab Emirates. These projects could be valued at over $100 billion.
What Happened: Executives from TSMC have recently visited the UAE to explore the possibility of establishing a plant complex comparable to their largest facilities in Taiwan. Similarly, senior leaders from Samsung have also visited the UAE to discuss potential chip-making operations in the region, The Wall Street Journal <a href="https://www.wsj.com/tech/ai/chip-giants-tsmc-and-samsung-discuss-building-middle-eastern-megafactories-65adc854?mod=hp_lead_pos3">reported</a> citing, people familiar with the interactions.
These discussions are in the preliminary stages and face significant technical and logistical challenges. The UAE would fund these projects, with Abu Dhabi-based sovereign development vehicle Mubadala playing a central role. Mubadala is eager to develop a domestic tech industry and increase global chip production.
The UAE&#8217;s ambitions reflect a broader global push to expand chip production to meet the demands of the AI boom. However, substantial technical and political hurdles remain, including the need for super-clean water and the availability of engineering talent.
Both TSMC and Samsung have had discussions with U.S. government officials regarding concerns about shipments of advanced AI chips to China, a trading partner of the UAE. These concerns need to be resolved before construction can begin, according to the report.
&#8220;We are always open to constructive discussion on ways to promote development of the semiconductor industry, but we remain focused on our current global expansion projects and&nbsp;have no new investment plans to disclose at this time,&#8221; a TSMC spokesperson told Benzinga in an email inquiry. 
Samsung did not immediately respond to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40946963/bitcoin-worth-63-000-pulled-in-33-pack-of-trading-cards-at-gamestop-mind-boggling-story-go?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin Worth $63,000 Pulled In $33 Pack Of Trading Cards At GameStop: ‘Mind-Boggling' Story Goes Viral, Highlights Crypto Redemption Card</a>
Why It Matters: The discussions between TSMC and Samsung come at a time when the Middle East is becoming increasingly significant in the global semiconductor landscape. 
Microsoft Corp. recently called for <a href="https://www.benzinga.com/news/24/09/40912608/microsoft-wants-clarity-on-chip-exports-to-middle-east-amid-1-4b-deal-with-uae-firm">more transparency on U.S. export controls</a> that have delayed the delivery of AI chips to the region. The company had invested $1.5 billion in G42, the largest AI company in the UAE, to use it as a gateway to markets in Africa and Asia.
Additionally, NVIDIA Corp has begun supplying its <a href="https://www.benzinga.com/news/24/09/40912608/microsoft-wants-clarity-on-chip-exports-to-middle-east-amid-1-4b-deal-with-uae-firm">advanced chips to Saudi Arabia</a>, positively influencing market sentiment in the Middle East and Asia. This move came after the U.S. reassessed its advanced semiconductor sanctions on Saudi Arabia, initially imposed in 2023 due to national security concerns.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40912814/amazon-told-its-staff-they-must-come-to-office-five-days-a-week-but-its-primary-healthcare-subsi?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amazon Told Its Staff They Must Come To Office Five Days A Week, But Its One Medical Subsidiary Workers Reportedly Have It Easier: E-commerce Giant Denies Report</a></li>
</ul>
Image Via Shutterstock 
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Global

Tech

MSFT

NVDA

SSNLF

TSMC And Samsung Explore $100B Chip Megafactories In UAE Amid AI Boom And Global Expansion Plans: Report

Leading coins were among the gains Sunday overnight after Democratic presidential nominee Kamala Harris mentioned cryptocurrencies for the first time during her election campaign.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 9:45 p.m. EDT)</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>+1.13%</td>
<td>$63,890.89</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+0.04%</td>
<td>$2,611.43</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>-1.64%</td>
<td>$0.1077</td>
</tr>
</tbody>
</table>
</figure>
What Happened: Bitcoin broke out of its sideways movement and nearly touched $64,000 as news of <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40972902/kamala-harris-finally-mentions-crypto-and-that-too-on-wall-street-promises-to-encourage-in">Harris' endorsement</a> started tricking in. The leading cryptocurrency experienced volatile price swings over the past few hours.
Ethereum too breached past $2,600, witnessing a substantial spike in trading volumes.
In the past 24 hours, 53,409 traders were liquidated, with the total liquidations at $131.21 million. Upside bets accounted for $86 million of the total liquidations.
Bitcoin's Open Interest rose marginally by 0.88% in the last 24 hours to $34.94 billion. The number of traders placing bearish bets on the coin surpassed those going long, as per Long/Short Ratio.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 9:45 p.m. EDT)</td>
</tr>
<tr>
<td>Helium (HNT)</td>
<td>+13.11%</td>
<td>$7.82</td>
</tr>
<tr>
<td>Sui (SUI)</td>
<td>+6.85%</td>
<td>$1.57</td>
</tr>
<tr>
<td>Bittensor (TAO)</td>
<td>+5.82%</td>
<td>$493.14</td>
</tr>
</tbody>
</table>
</figure>
The global cryptocurrency market stood at $2.23 trillion, following an increase of 0,54% in the last 24 hours.
Stock futures rose slightly overnight on Sunday. The Dow Jones Industrial Average Futures lifted 63 points, or 0.15%, as of 9:45 p.m. EDT.&nbsp; Futures tied to the S&amp;P 500 were up 0.27%, while Nasdaq 100 Futures gained 0.53%.
The uptick followed a record-breaking week that saw blue-chip indexes like the Dow and the S&amp;P 500 clocking new all-time highs <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead">after the Federal Reserve dropped interest rates</a> for the first time in more than four years.
Investors would keep an eye out for the manufacturing and service sector data due on Monday to further assess the soft landing scenario.
See More: <a href="https://www.benzinga.com/money/best-crypto-scanners">Best Cryptocurrency Scanners</a>
Analyst Notes: Widely-followed cryptocurrency analyst Kingpin Crypto indicated a probable retreat to the $60,000 range if $64,000 holds as resistance.&nbsp;&nbsp;
"If price starts closing above supply, then it&#8217;s game over for the bears as I see no resistance above until 70,000," the analyst remarked.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> &#8211; As long as price respects $64k resistance I still expect a brief rejection towards the red box. If price starts closing above supply, then it&#39;s game over for the bears as I see no resistance above until 70k. TL;DR. long either at redbox or above $64k, no shorts. <a href="https://t.co/zyBnU8UgZn">https://t.co/zyBnU8UgZn</a> <a href="https://t.co/VVED1JLwkA">pic.twitter.com/VVED1JLwkA</a>
&mdash; Kingpin Crypto (@Kingpincrypto12) <a href="https://twitter.com/Kingpincrypto12/status/1838037450007986376?ref_src=twsrc%5Etfw">September 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Prominent analyst Ali Martinez predicted an &#8220;altcoin season,&#8221; with the overall market capitalization reaching $1 trillion sooner rather than later.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/hashtag/altcoin?src=hash&amp;ref_src=twsrc%5Etfw">#altcoin</a> market cap looks primed to surpass $1 trillion&#8230; It is just a matter of time before <a href="https://twitter.com/hashtag/altcoinseason?src=hash&amp;ref_src=twsrc%5Etfw">#altcoinseason</a>! <a href="https://t.co/NRRa6v3ZOk">pic.twitter.com/NRRa6v3ZOk</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1837927091267834099?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also noted the diminishing Bitcoin dominance that would pave the way for an altcoin rally.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> dominance seems to be topping out, hinting at a possible dip to 47% — setting the stage for an <a href="https://twitter.com/hashtag/altcoinseason?src=hash&amp;ref_src=twsrc%5Etfw">#altcoinseason</a>! <a href="https://t.co/qkz4IziP8r">pic.twitter.com/qkz4IziP8r</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1837986986331947251?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Photo by Avi Rozen on Shutterstock
Read Next:    
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40971599/well-its-crypto-its-ai-its-some-of-the-other-things-says-donald-trump-unsure-of-what-his-n">&#8216;Well, It&#8217;s Crypto, It&#8217;s AI, It&#8217;s Some Of The Other Things,&#8217; Says Donald Trump, Unsure Of What His New Crypto Project Even Is</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

$BTC

$DOGE

$ETH

Bitcoin, Ethereum Rise, Dogecoin Slips As Market Reacts To Harris' Crypto Mention: Analyst Believes It'll Be 'Game Over' For Bears If King Crypto Breaches $64K

Sen. Lindsey Graham (R-S.C.) has called for a new approach to Middle East policy, advocating for either a &#8220;game changing peace&#8221; or a &#8220;game changing military strategy.&#8221;
What Happened: On Thursday, Graham expressed his views on Middle East policy via X. He suggested that a significant shift in strategy is needed, either through Saudi Arabia recognizing Israel, or Israel taking military action against Iran.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">In the Middle East, we need game changing peace or game changing military strategy. Game changing peace begins with Saudi Arabia recognizing the state of Israel. Game changing military strategy begins with Israel targeting Iran, the source of chaos in the region. <a href="https://t.co/qFD9ZxQY1t">pic.twitter.com/qFD9ZxQY1t</a>
&mdash; Lindsey Graham (@LindseyGrahamSC) <a href="https://twitter.com/LindseyGrahamSC/status/1837981953150345568?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Graham&#8217;s tweet comes in the wake of a series of deadly escalation between Israel and Hezbollah. Israel and Hezbollah exchanged heavy fire, with Hezbollah launching over 100 rockets into northern Israel in response to Israeli strikes on Lebanon, <a href="https://apnews.com/article/israel-lebanon-hezbollah-news-09-22-2024-fb1aa8ae061885ba86855f7fe9ec5be7">reported</a> AP on Sunday.
The conflict escalated after an Israeli airstrike in Beirut killed several people, including a senior Hezbollah commander. Hezbollah declared an "open-ended battle," while Israel launched hundreds of strikes, targeting militant sites. Both sides suffered casualties, and the situation raised concerns about the potential for a broader conflict.
See Also: <a href="https://www.benzinga.com/news/24/09/40969584/trump-vs-harris-this-candidate-has-the-edge-in-latest-swing-state-polls?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs Harris: This Candidate Has The Edge In Latest Swing State Polls</a>
Why It Matters: The recent <a href="https://www.benzinga.com/news/24/09/40924166/hezbollah-hit-in-new-round-of-explosions-across-lebanon-casualties-climb">wave of explosions</a> in Lebanon have escalated tensions in the region. The attacks, believed to be targeted at Hezbollah, an Iran-backed group, have resulted in significant casualties and damage.
Lebanon recently grappled with a <a href="https://www.benzinga.com/news/24/09/40924166/hezbollah-hit-in-new-round-of-explosions-across-lebanon-casualties-climb">second wave of deadly explosions</a> targeting Hezbollah, as wireless devices like walkie-talkies detonated across the country, killing at least nine and injuring over 300. The attacks, which Hezbollah blamed on Israel, followed an earlier wave of pager explosions that killed 12 and injured nearly 2,800.
Graham&#8217;s tweet and the recent events in Lebanon highlight the urgent need for a resolution to the ongoing conflict in the Middle East. Whether this will involve diplomatic recognition or military action remains to be seen.
Photo via Shutterstock
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Lindsey Graham Says Either Saudi Arabia Recogonizes Israel Or Tel Aviv Targets Tehran: 'We Need Game Changing Peace Or Game Changing Military Strategy'

Sen. Bernie Sanders (I-Vt.) has once again criticized Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) for the high price of its diabetes drug, Ozempic, in the United States.
What Happened: On Sunday, Sanders took to X to express his concerns about the pricing disparity of Ozempic in the U.S. compared to other countries. 
He highlighted that generic drug companies can sell Ozempic at a profit for less than $100, while Americans are paying almost $1,000 a month for the drug. Sanders attributed this price discrepancy to corporate greed and called on Novo Nordisk to reduce the price of Ozempic.
He said, &#8220;So why does your prescription cost more than a luxury handbag?&#8221;
Sanders&#8217; post featured a video in which Zain Rizvi a Senior Health Counsel at the Senate Committee on Health, Education, Labor, and Pensions stated that the rich, powerful and famous could get access to such drugs, but everyone else struggled due to the high costs of such prescriptions.
Among the issues addressed in the video was the cost of manufacturing of drugs such as Ozempic and Wegovy, which according to Rizvi&#8217;s video could be made under $5. Rizvi said that major pharmaceutical companies had told HELP committee that they can sell Ozempic to Americans for less than $100 a month.
&#8220;The problem? Novo Nordisk is taking companies to court to stop them from selling low-cost generic versions.&#8221;
He accused Novo Nordisk of following the big pharma playbook by putting &#8220;patents above public health.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Generic drug companies can sell Ozempic — at a profit— for less than $100. But Americans are paying almost $1,000 a month for the drug. So why does your prescription cost more than a luxury handbag? Corporate greed. Novo Nordisk must lower the price of Ozempic. <a href="https://t.co/oCROGpVxtU">pic.twitter.com/oCROGpVxtU</a>
&mdash; Bernie Sanders (@SenSanders) <a href="https://twitter.com/SenSanders/status/1838005900717494781?ref_src=twsrc%5Etfw">September 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Benzinga has reached out to Novo Nordisk and this story will be updated as soon as we receive a response.
See Also: <a href="https://www.benzinga.com/news/24/09/40969978/mary-trump-says-americans-pay-the-price-as-her-uncle-sets-world-on-fire-with-his-provocations-i-worr?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mary Trump Says Americans Pay The Price As Her Uncle Sets World On Fire With His Provocations: &#8216;I Worry About What Will Happen&#8217;</a>
Why It Matters: This is <a href="https://www.benzinga.com/news/24/03/38012469/bernie-sanders-slams-outrageous-prices-of-miracle-weight-loss-drug-ozempic-mulls-meeting-with-novo-n">not the first time</a> Sanders has targeted Novo Nordisk over the pricing of Ozempic. In March it was reported that Sanders, who chairs the HELP committee, was considering holding hearings on the issue and seeking a meeting with the company's CEO to discuss reducing the drug's price. 
Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence that Novo Nordisk could be persuaded to lower U.S. prices for its weight-loss drugs, Ozempic and Wegovy, by <a href="https://www.benzinga.com/general/biotech/24/07/39736330/bernie-sanders-targets-high-prices-of-ozempic-and-wegovy-in-us">exposing price disparities</a>.
He has also predicted that Ozempic will likely become one of the <a href="https://www.benzinga.com/news/24/06/39515914/bernie-sanders-ozempic-will-likely-become-one-of-the-best-selling-pharmaceutical-products-in-history">best-selling pharmaceutical products</a> in history. The high cost of the drug has been a point of contention, with Sanders arguing that Americans should not be charged excessively for this drug compared to people in other countries.
Image via Shutterstock
Did You Know?
Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100

Democratic presidential candidate Kamala Harris formally referenced cryptocurrency for the first time during her election campaign, promising to safeguard the industry&#8217;s interests.
What happened: During a fundraiser at Cipriani Wall Street in Manhattan, the incumbent vice president marketed her pro-emerging technology agenda, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-09-22/harris-vows-to-grow-ai-crypto-industries-in-pitch-to-nyc-donors?utm_source=twitter&amp;utm_campaign=socialflow-organic&amp;utm_medium=social&amp;utm_content=crypto">reported </a>Sunday.&nbsp;
"We will partner together to invest in America's competitiveness, to invest in America's future. We will encourage innovative technologies like AI and digital assets, while protecting our consumers and investors," Harris said.
The first public mention of cryptocurrency elicited cheers from Harris campaign supporters.&nbsp;
Rep. Wiley Nickel (D-N.C.) dubbed it a "huge" policy development and a significant reset on her positions on cryptocurrencies and blockchains.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f6a8;Huge policy news! <a href="https://twitter.com/KamalaHarris?ref_src=twsrc%5Etfw">@KamalaHarris</a> signals a very significant reset on crypto and blockchain technology. This new policy position puts her in line with <a href="https://twitter.com/hashtag/FIT21?src=hash&amp;ref_src=twsrc%5Etfw">#FIT21</a> House and Senate Democrats working to protect consumers and keep digital innovation in the United States. &#x1f1fa;&#x1f1f8; <a href="https://t.co/tSNudVGJsw">https://t.co/tSNudVGJsw</a>
&mdash; Rep. Wiley Nickel &#x1f1fa;&#x1f1f8; (@WileyNickel) <a href="https://twitter.com/WileyNickel/status/1837966805970964686?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Anthony Scaramucci, CEO of investment firm SkyBridge Capital, said, "Kamala means Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) in every language."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Kamala means Bitcoin in every language
&mdash; Anthony Scaramucci (@Scaramucci) <a href="https://twitter.com/Scaramucci/status/1838016216645914765?ref_src=twsrc%5Etfw">September 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40950912/bitcoins-reserve-asset-appeal-increased-due-to-state-of-us-federal-deficit-and-debt-says-b">Bitcoin&#8217;s Reserve Asset Appeal Increased Due To State Of US Federal Deficit And Debt, Says BlackRock: A Hedge Against &#8216;Possible Future Events&#8217; Affecting The Dollar</a>
Why It Matters: Cryptocurrency has emerged as a significant election issue this year, with <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39136615/survey-crypto-stance-could-sway-one-third-of-2024-voters">one survey indicating that one-third of voters</a> will consider a candidate's stance on digital assets before making their political choices.&nbsp;
Former President Donald Trump has taken the lead in courting the expanding population, and the Republican contender even <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40905315/donald-trumps-new-crypto-project-world-liberty-financial-everything-you-need-to-know">launched a cryptocurrency project</a> right before the November elections.
Until the latest acknowledgment, Harris's stance on cryptocurrencies was unclear, though <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40385566/mark-cuban-gets-an-assurance-out-of-chuck-schumer-will-pass-sensible-and-long-lasting-cryp">advocacy groups like &#8220;Crypto for Harris&#8221;</a> have been trying to muster support for her and counterbalance Trump's campaign.
Price Action: At the time of writing, Bitcoin was exchanging hands at $63,887.21, up 1.07% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Image via Wikimedia Commons
Did You Know?&nbsp;
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>

Kamala Harris Finally Mentions Crypto And That Too On Wall Street: Promises To Encourage 'Innovative Technologies' Like Digital Assets

Peter Schiff, a prominent gold advocate and vocal critic of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), has raised concerns about former President Donald Trump&#8216;s recent promise of a Mars landing. Schiff&#8217;s critique draws parallels between current economic challenges and historical spending on space exploration and social programs.
What Happened: In a post on social media platform X, Schiff <a href="https://x.com/PeterSchiff/status/1837640136600801783">stated</a>, &#8220;The reason we had so much inflation during the 1970s was the deficit spending during the 1960s on the Great Society, the War on Poverty, the Vietnam War (we lost both wars), and going to the moon. Now, with the U.S. in worse financial shape, Trump has promised a Mars landing.&#8221;
Schiff&#8217;s remarks follow Trump&#8217;s recent <a href="https://x.com/elonmusk/status/1837592820338905214">declaration</a> that the U.S. is leading in space over Russia and China, with plans to collaborate with Elon Musk to expedite a Mars landing before the end of his term.
Meanwhile, SpaceX and Tesla Inc CEO Musk has outlined ambitious plans for Mars exploration. Musk detailed a timeline that includes launching five uncrewed Starships to Mars within two years, with potential crewed missions in four years if these initial landings prove successful.
Musk emphasized the importance of making Mars travel accessible, stating, &#8220;We want to enable anyone who wants to be a space traveler to go to Mars!&#8221; He also expressed concerns about regulatory hurdles, noting that &#8220;the Starship program is being smothered by a mountain of government bureaucracy that grows every year.&#8221;
In response to Musk&#8217;s post, Schiff commented, &#8220;I have no issues with SpaceX going to Mars. I just don&#8217;t want the government to do it.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I agree that democrats are worse than republicans. But there are plenty of republican supported regulations that also need to be repealed. Hopefully you will be able to help bring that about. I have no issues with SpaceX going to Mars. I just don&#39;t want the government to do it.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1837922682081366157?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/09/40970828/data-scientists-election-prediction-kamala-harris-receives-historic-endorsement-from-magazine-elon-m">Data Scientist&#8217;s Election Prediction, Kamala Harris Receives Historic Endorsement From Magazine, Elon Musk Suggests Warren Buffett Is Preparing For A Harris Win And More: Top Political Update This Week</a>
Why It Matters: The debate over space exploration has intensified recently, with Musk facing regulatory hurdles for SpaceX. Rep.&nbsp;Kevin Kiley&nbsp;(R-Calif.) recently <a href="https://www.benzinga.com/government/24/09/40972034/elon-musk-responds-as-california-congressman-slams-bureaucratic-roadblocks-for-spacex-program-agenci">praised SpaceX&#8217;s Polaris Dawn</a> mission but criticized bureaucratic obstacles. The mission, which launched on Sept. 10, saw a private crewed spaceflight reach the farthest distance from Earth since NASA&#8217;s Apollo program.
Additionally, Musk&#8217;s recent endorsement of Trump for the <a href="https://www.benzinga.com/24/09/40971977/elon-musk-says-biden-belied-his-2020-expectations-and-turned-out-to-be-a-radical-leftist-puppet-why">2024 presidential race</a> has added another layer to the political discourse. Musk, who previously leaned towards Joe Biden, now describes him as a &#8220;radical leftist puppet.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/24/09/40971374/elon-musk-responds-to-venture-capitalists-claim-on-government-subsidies-for-spacex-tesla-do-some-res">Elon Musk Responds to Venture Capitalist&#8217;s Claim On Government Subsidies For SpaceX, Tesla: &#8216;Do Some Research Before You Display Your Utter Ignorance&#8217;</a></li>
</ul>
Images via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

SPACE

Trump's Mars Landing Promise Gets Slammed By Peter Schiff Even As Elon Musk Says SpaceX Plans 5 Launches To Red Planet In 2 Years: 'Just Don't Want The Government To Do It'

Jeff Bezos-backed Perplexity AI, <a href="https://www.benzinga.com/news/24/03/37421021/this-jeff-bezos-backed-ai-tool-can-replace-search-engine-for-many-people-says-top-ex-googler-but-the">a&nbsp;startup challenging</a>&nbsp;Alphabet Inc.‘s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, is in discussions with top brands like Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) and Marriott International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>).
What Happened: Perplexity&nbsp;is developing a &#8220;sponsored&#8221; question system to challenge Google&#8217;s auction-based ads model, as it plans to <a href="https://www.benzinga.com/news/24/08/40523773/jeff-bezos-backed-perplexity-ai-gears-up-to-integrate-ads-in-search-results-taking-a-leaf-out-of-goo">disrupt the tech giant&#8217;s dominance</a> in&nbsp;the $300 billion digital ads industry, <a href="https://www.ft.com/content/ecf299f4-e0a9-468b-af06-8a94e5f0b1f4">reported</a> Financial Times.
The San Francisco-based startup has been in talks with a select group of top-tier companies, including&nbsp;Nike&nbsp;and&nbsp;Marriott, with plans to launch the ads system by year-end.
Perplexity&#8217;s new model allows brands to bid for a &#8220;sponsored&#8221; question featuring&nbsp;an AI-generated answer approved by&nbsp;the advertiser.
See Also:&nbsp;<a href="https://www.benzinga.com/news/23/05/32623067/how-to-take-the-perfect-moon-shot-using-an-iphone-14?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">How To Take The Perfect Moon Shot Using An iPhone 15</a>
Perplexity CEO Aravind Srinivas, a former Google intern, stated, &#8220;Ads are really useful when they are relevant and coming from brands that are high quality, and a lot of people make purchases based on that.&#8221;
Srinivas expressed his ambition for the advertising system to become &#8220;a money-printing machine.&#8221;
The startup&#8217;s ad system will charge marketers on a CPM basis, costing&nbsp;above $50 for every 1,000&nbsp;impressions generated by these sponsored&nbsp;posts.
This is in stark contrast to Google&#8217;s&nbsp;estimated $1,100 for the same&nbsp;number of impressions, the report noted.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters:&nbsp;In April earlier this year, <a href="https://www.benzinga.com/news/24/04/38398735/jeff-bezos-backed-perplexity-ai-is-now-a-unicorn-after-latest-fundraise-softbanks-masayoshi-son-nvid">Perplexity&nbsp;became a unicorn</a>, following a successful funding round that more than doubled its valuation to over $1 billion.
The startup&#8217;s revenue and usage have grown 700% since the start of the year, with the AI-powered search engine answering about <a href="https://www.benzinga.com/general/entrepreneurship/24/08/40292703/perplexity-ais-revenue-usage-skyrocket-as-it-enters-into-advertising">250 million questions in the last month</a>, up from 500 million queries for all of last year.
Perplexity investors include AI chipmaker&nbsp;Nvidia Corporation, Amazon&nbsp;founder&nbsp;Bezos,&nbsp;OpenAI&nbsp;co-founder&nbsp;Andrej Karpathy, and&nbsp;Meta Platform Inc.&#8216;s chief AI scientist&nbsp;Yann LeCun.
In June, Forbes and Wired accused Perplexity of plagiarism, alleging that the AI startup replicated articles without proper attribution and accessed websites that had specifically blocked its crawlers.
Perplexity acknowledged the claims in response, stating that the company had updated its user interface to highlight citations more clearly and adjusted its system to avoid summarizing content from such websites.
Photo courtesy: Shutterstock
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40851084/mark-cuban-was-once-tending-a-bar-in-dallas-but-quickly-realized-he-wasnt-great-at-working-for-peopl?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Was Once Tending A Bar In Dallas But Quickly Realized He Wasn&#8217;t Great At Working For People</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Media

GOOG

GOOGL

Jeff Bezos-Backed Perplexity AI In Discussion With Marriott And Nike As It Prepares To Challenge To Google's Dominance

&#8220;Shark Tank&#8221; fame billionaire Mark Cuban recently slammed hedge fund manager and founder of Pershing Square Capital Management Bill Ackman&#8217;s views on the candidacy of Kamala Harris.
What Happened: Cuban responded to a post by Bill Ackman, which criticized Harris&#8217;s candidacy and the circumstances surrounding her rise to the presidential nominee position. Ackman accused Harris of being complicit in what he called &#8220;the greatest lie ever told to the American people by our government,&#8221; referring to the health status of former President Joe Biden.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Let's not forget that <a href="https://twitter.com/POTUS?ref_src=twsrc%5Etfw">@POTUS</a> Biden was the Democratic presidential candidate 63 days ago. We were told by the administration and the media that Biden was in perfect health and that videos of him exhibiting serious deterioration were ‘right wing propaganda.' Then, threatened… <a href="https://t.co/QHtVdhawJY">https://t.co/QHtVdhawJY</a>
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1837777743464865852?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/09/40953535/anybody-who-votes-for-a-democrat-or-kamala-worst-you-should-have-your-head-examined-trump-tells-vote?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Anybody Who Votes For A Democrat Or Kamala, Worst…You Should Have Your Head Examined:&#8217; Trump Tells Voter</a>
Ackman also expressed his disappointment with Harris&#8217;s campaign strategy, accusing her of evading direct questions about the economy, the border, or foreign policy. He suggested that her campaign was a blatant attempt to say what she needs to say to get elected.
Cuban said in <a href="https://x.com/mcuban/status/1837833875571069414?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1837833875571069414%7Ctwgr%5E8e4c71f4fa37fc5a73a1c473e778646c0b22e9c3%7Ctwcon%5Es1_c10&amp;ref_url=https%3A%2F%2Feditorial.benzinga.com%2Fwp-admin%2Fpost.php%3Fpost%3D560083action%3Dedit">response</a>: &#8216;When the competition hires a new CEO and she is kicking your a&#x2A;&#x2A; …&#8217;
Why It Matters: Cuban&#8217;s critical response to Ackman&#8217;s thread comes amidst a <a href="https://www.benzinga.com/news/24/09/40971721/voters-warm-to-kamala-harris-as-election-nears">surge in Harris&#8217;s popularity</a> Recent polls suggest a slight advantage for Harris over Trump, with a Morning Consult poll showing Harris leading by 6 percentage points nationwide.
Notably, Cuban, a supporter of the vice president, had previously expressed some skepticism about Harris&#8217;s economic proposals. In August, he engaged in a storm of posts about Harris&#8217;s economic plans, particularly around the <a href="https://www.benzinga.com/personal-finance/24/08/40544099/mark-cuban-responds-to-kamala-harris-economic-plan-with-dozens-of-tweets-says-she-didnt-mention-">issue of price controls</a>.
Cuban&#8217;s relationship with Donald Trump, the other presidential candidate, has been <a href="https://www.benzinga.com/startups/24/08/40582769/mark-cuban-now-calls-trump-a-snake-oil-salesperson-but-reveals-they-were-once-so-friendly-that-trump">complicated</a>. He once referred to Trump as a &#8220;snake oil salesperson,&#8221; but admitted they were once on good terms, with the former president even seeking his advice on stocks at one point.
Photo courtesy: Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Mark Cuban Issues A Stinging Retort To Bill Ackman's Attack On Kamala Harris: 'She Is Kicking Your A**…'

Former President Donald Trump has declared that he will not pursue another presidential run if he is defeated in the forthcoming November election.
What Happened: Trump, in a conversation with Sinclair Broadcast Group&#8217;s &#8220;Full Measure&#8221; on Sunday, dismissed the idea of another presidential run if he loses the upcoming election, as reported by <a href="https://abcnews.go.com/Politics/trump-run-loses-november/story?id=113910212">ABC News</a>.
When asked by host Sharyl Attkisson about another run, he replied, &#8220;I don&#8217;t see that at all. I think that, hopefully, we&#8217;re going to be successful.&#8221;
Trump, currently the oldest presidential nominee in history, is in the race following President Biden&#8217;s decision not to run for the 2024 election. Age and mental acuity have been significant concerns in this election cycle.
Amid his third presidential bid, Trump has been balancing his campaign activities with court appearances related to four criminal cases against him.
See Also: <a href="https://www.benzinga.com/24/09/40954613/kim-jong-uns-show-of-force-with-missiles-indicates-north-korea-is-no-longer-interested-in-negotiatio?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Kim Jong Un&#8217;s &#8216;Show Of Force&#8217; With Missiles Indicates North Korea Is No Longer Interested In Negotiations</a>
Why It Matters: The 2024 presidential election has seen a tight contest between Trump and Vice President Kamala Harris. Recent polling data, including over 20 swing-state polls conducted post the September 10 debate, suggests a <a href="https://www.benzinga.com/news/24/09/40969584/trump-vs-harris-this-candidate-has-the-edge-in-latest-swing-state-polls">slight lead</a> for Harris over Trump. 
Despite Harris trending upwards in the polls, Trump has been <a href="https://www.benzinga.com/general/politics/24/09/40949853/harris-in-trouble-new-swing-state-poll-shows-trump-gains-ground-in-key-battleground-areas-for-20">gaining ground</a> in key battleground areas. The election could hinge on the results from these swing states. 
Meanwhile, Harris has seen a surge in popularity with a <a href="https://www.benzinga.com/news/24/09/40971721/voters-warm-to-kamala-harris-as-election-nears">significant uptick</a> in her favorability. This shift is noteworthy, given her previously low polling figures. 
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Trump Says No To Another Run If He Loses 2024 Election To Kamala Harris: 'Hopefully, We're Going To Be Successful'

House GOP leaders have put forth a three-month plan to keep the government funded, in the wake of Speaker Mike Johnson&#8217;s (R-La.) initial plan failing due to Republican opposition.
What Happened: The continuing resolution (CR) was a product of bipartisan negotiations in the House and Senate. The resolution, which maintains current funding levels until December 20, sets the stage for a holiday funding battle. The three-month timeframe is a reduction from Johnson&#8217;s initial six-month proposal and notably omits a Donald Trump-endorsed measure requiring proof of citizenship to vote, <a href="https://thehill.com/homenews/house/4892931-government-funding-continuing-resolution-deal-mike-johnson/">reported</a> The Hill.
Republican leaders aim to bring the bill to a floor vote by Wednesday, with the goal of sending it to the Senate before the September 30 shutdown deadline. Johnson warned Republicans against a shutdown, stating in a &#8220;Dear Colleague&#8221; letter, &#8220;As history has taught and current polling affirms, shutting the government down less than 40 days from a fateful election would be an act of political malpractice.&#8221;
The bill also earmarks $231 million for the Secret Service, which has recently come under scrutiny following an apparent second assassination attempt against former President Trump. Johnson characterized the legislation as &#8220;a very narrow, bare-bones CR including only the extensions that are absolutely necessary.&#8221;
House Republicans will likely require Democratic support to pass the legislation, as many GOP lawmakers are anticipated to oppose the bill due to the lack of spending cuts, shorter timeframe, and exclusion of the voting bill. The bill&#8217;s passage may face obstacles as it will need to clear a procedural vote, which are traditionally party-line affairs.
See Also: <a href="https://www.benzinga.com/news/24/09/40967938/jpmorgan-ceo-jamie-dimon-calls-for-federal-employees-to-return-to-office-says-empty-buildings-bother?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">JPMorgan CEO Jamie Dimon Calls For Federal Employees To Return To Office, Says Empty Buildings &#8216;Bother&#8217; Him: &#8216;I Can&#8217;t Believe&#8230;&#8217;</a>
Why It Matters: This development follows the <a href="https://www.benzinga.com/news/24/09/40931809/house-republicans-reject-their-own-funding-bill-as-government-shutdown-looms-mike-johnson-says-we-ha">rejection</a> of Speaker Johnson&#8217;s initial funding bill by House Republicans. The failure of the bill complicated efforts to avert a government shutdown at the end of the month.
Earlier, Senate Majority Leader, Chuck Schumer (D-N.Y.), had warned of potential blame for a government shutdown due to "Republican poison pills." He cautioned that the American public would hold Republicans accountable if a shutdown occurs.
Photo via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

House GOP Leaders Pitch 3-Month Funding Plan, Drop Trump-Backed Voter ID Proposal: Mike Johnson Says Shutting Government Down 40 Days From Election Is 'Political Malpractice'

With over 100 patents and 30 years of experience in food, pharmaceutical, and cannabis packaging, Jim Sanfilippo is transforming cannabis safety.
His groundbreaking cryogenic pasteurization technology at VIST Labs is solving one of the industry&#8217;s dirtiest secrets: microbial contamination.
Operating in a $35 billion market, Sanfilippo's innovations are crucial for cannabis brands striving to maintain product integrity while navigating complex regulatory challenges.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">From Nuts To Frozen Nuggs</h3>
Sanfilippo's expertise in packaging dates back to his family's food business, where his innovations in oxygen-free packaging for nuts led to breakthroughs in the food and pharmaceutical sectors. He has spent decades optimizing shelf life and safety. In 2017, after selling two divisions of his business to packing behemoth Sonoco, he turned his attention to cannabis.
&#8220;Cannabis is a $35 billion industry in the U.S.,&#8221; Sanfilippo said, noting that its microbial contamination issues are particularly concerning​.
<h3 class="wp-block-heading">Cryogenic Pasteurization: The Cannabis Industry's Dirty Little Secret</h3>
At the heart of <a href="https://vistlabs.com/">VIST Labs' breakthrough</a> is the cryogenic pasteurization process, which leverages medical-grade cryogenic vapor to<a href="https://www.benzinga.com/general/biotech/24/09/40820581/want-organic-cannabis-operators-are-turning-to-this-tech-to-save-millions-and-get-certified"> sterilize cannabis products</a> while preserving their natural properties. "Cannabis is heavily contaminated with yeast, mold, and pathogens like Aspergillus," Sanfilippo explained.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="685" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-1024x685.jpg" alt="" class="wp-image-559846" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-1024x685.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-300x201.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585-768x513.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21191401/DSC06585.jpg 1300w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Courtesy of VIST </figcaption></figure>
He says that traditional methods, such as gamma <a href="https://www.benzinga.com/general/biotech/23/02/30699860/from-food-to-cannabis-buds-x-rays-are-transforming-supply-chains-an-expert-explains-how-and-why">radiation</a> or ozone, can damage cannabinoids and terpenes, leading to degraded quality.
How does it work?
<h3 class="wp-block-heading">Freeze Microbes! </h3>
VIST&#8217;s solution reduces oxygen levels to a point where oxidation and microbial growth are halted, without affecting the product's integrity​. The process begins by placing cannabis into a product cassette, holding 4-5 pounds. This cassette is loaded into the pasteurization machine &#8211; a refrigerator-sized unit &#8211; where the chamber is then prepared with cryogenic vapor.
In the next step, the vapor-induced sterilization chamber (VIST chamber) is activated. Inside this chamber, cryogenic vapor, which is created by boiling off liquid nitrogen at -320 degrees Fahrenheit, mixes with a medical-grade atmosphere.
Within 90 to 150 seconds, the vapor floods the chamber, bringing oxygen levels to extremely low concentrations (around 95% cryogenic vapor), which kills harmful microbial organisms like <a href="https://www.benzinga.com/markets/cannabis/24/07/39584632/mold-and-yeast-sixth-marijuana-recall-this-year-hits-colorado-cannabis-dispensaries">Aspergillus, E. coli, and Salmonella</a>.
After the sterilization, the product is quickly cools down using liquid nitrogen, preventing oxidation during the process. Finally, the cannabis is purified with a HEPA filtration system, removing any remaining airborne contaminants and ensuring stability as the product is packaged in aseptic, low-oxygen conditions​.
Read Also: <a href="https://www.benzinga.com/news/24/09/40941818/how-this-cheese-aging-tech-is-boosting-profits-for-cannabis-growers-stop-throwing-cheddar-out-the-do">How This Cheese-Aging Tech Is Boosting Profits For Cannabis Growers: Stop Throwing Cheddar Out The Door</a>
<h3 class="wp-block-heading">A Modular Solution For Cannabis Business</h3>
VIST Labs' cryogenic pasteurization machines are designed to be modular, offering flexibility for mid-sized cultivators as well as large-scale operations. "We can run it in cassette mode at 25 pounds per hour, or upgrade to our high-output configuration, reaching up to 40 pounds per hour," Sanfilippo told Benzinga.
VIST Labs' cryogenic pasteurization system isn't just a machine, it's a<a href="https://www.benzinga.com/general/biotech/23/08/33579692/cannabis-robots-meet-the-company-boosting-efficiency-and-margins-through-packaging-automation"> fully integrated packaging solution</a>. After the sterilization process, the product is transferred into a bulk device that packs cannabis into different bag sizes, from one to ten-pound bags, or a pouch line for smaller quantities like an eighth-ounce. &#8220;We have the cooler, a pouch bagger, and other parts working together to maintain the product in a near-zero oxygen atmosphere," Sanfilippo explained.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="600" height="600" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment.png" alt="" class="wp-image-559842" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment.png 600w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment-300x300.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/21190952/AMAPS-Equipment-150x150.png 150w" sizes="(max-width: 600px) 100vw, 600px" /><figcaption class="wp-element-caption">Courtesy of VIST </figcaption></figure>
This scalability makes VIST's technology accessible to a wide range of businesses, whether they are aiming for compliance in medical markets or looking to protect their medical-grade level crop for export.
The company's aseptic packaging solutions meet European Pharmacopoeia standards, ensuring <a href="https://www.benzinga.com/markets/cannabis/24/06/39442869/2-9b-european-cannabis-market-a-strategic-blueprint-for-cross-border-transportation-logistics">compliance </a>in both domestic and international markets.
VIST's technology is also forward-thinking, preparing cannabis brands for potential federal legalization. With the increasing possibility of federal oversight, Sanfilippo notes that stricter regulations, especially around truth-in-labeling, will make compliance technologies like theirs essential for long-term success.
&#8220;With our system, we're offering crop-year protection and complete microbial control for up to a year," Sanfilippo said, noting that VIST expects to pack close to 150 million pounds of outdoor-grown cannabis in 2023 alone​.
<h3 class="wp-block-heading">Contamination And Mislabeling&#8230;Not A Problem</h3>
Beyond decontamination, VIST's system tackles a major issue in the cannabis industry: the degradation of THC potency over time. Inconsistent oxygen levels in packaging lead to mislabeled products, which can result in recalls and regulatory action.
&#8220;Within 45 to 50 days, THC levels can degrade by 10% or more, rendering the label claims false,&#8221; said Sanfilippo. VIST's modified atmosphere packaging (MAP) ensures stability for up to a year, keeping products compliant and safe.
Read Next: <a href="https://www.benzinga.com/general/biotech/24/08/40298228/think-you-can-do-it-all-20-000-reasons-why-automation-outperforms-a-broad-approach-in-cannabis">Think You Can Do It All? 20,000 Reasons Why Automation Outperforms A Broad Approach In Cannabis</a>

Cannabis

Entrepreneurship

Management

Success Stories

Small Business

Exclusives

Interview

X-Rays, Microwaves And Now What? This Company Freezes Weed At -320°F To Kill Mold And Save A Ton

This week, the Federal Reserve's decision to reduce interest rates by 50 basis points boosted share prices across the technology, construction, <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40937291/bank-stocks-hit-inflection-point-after-feds-50-basis-point-cut-analyst-reveal-top-p" rel="noreferrer noopener">industrial, machinery, and financial sectors</a>.
These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Edgewise Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) shares rocketed 50.19% after the company announced topline data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm of the Phase 2 CIRRUS-<a href="https://www.benzinga.com//node/40940696" target="_blank" rel="noreferrer noopener">HCM trial in patients with obstructive HCM</a>.</li>
<li>Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) stock gained 28.36% after <a href="https://www.benzinga.com//node/40884021" target="_blank" rel="noreferrer noopener">reportedly considering a sale</a>.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) shares upped 27.06%. The company's subsidiary Bausch + Lomb Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) <a href="https://www.benzinga.com//node/40884021" target="_blank" rel="noreferrer noopener">is reportedly considering a sale</a>.</li>
<li>Ascendis Pharma A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) stock gained 26.87% last week after the company announced <a href="https://www.benzinga.com//node/40882593" target="_blank" rel="noreferrer noopener">topline data from</a> its pivotal approach trial of a rare dwarfism candidate.</li>
<li>Nuvalent Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>) stock gained 23.50% after the company <a href="https://www.benzinga.com//node/40865049" target="_blank" rel="noreferrer noopener">highlighted results for its ROS1 and ALK-Positive NSCLC programs</a> and accelerated its development timeline. The company also announced a $350 million public offering, and multiple firms raised their respective <a href="https://www.benzinga.com/quote/nuvl/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) stock gained 22.61% last week as stocks in the broader industrial space jumped following the Fed's announcement to cut rates by 50 basis points, which could support investment and economic growth.</li>
<li>GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) shares jumped 21.28%.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972008/constellation-energy-li-auto-and-carvana-are-among-top-11-large-cap-gainers-last-week-sept-16-sept" target="_blank" rel="noreferrer noopener">Constellation Energy, Li Auto And Carvana Are Among Top 11 Large Cap Gainers Last Week (Sept 16-Sept 20): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972060/novo-nordisk-chewy-and-fedex-are-among-top-10-large-cap-losers-last-week-sept-15-sept-21-are-the-o" target="_blank" rel="noreferrer noopener">Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Mid Cap

ASND

BLCO

EWTX

NUVL

POWL

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) stock declined 23.61%. The company announced that data for the novel, potential first-in-class investigational bispecific antibody, ivonescimab, was presented <a href="https://www.benzinga.com//node/40873837" target="_blank" rel="noreferrer noopener">at the 2024 ESMO Annual Meeting</a>.</li>
<li>Joint Stock Company Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) stock tumbled 21.66% after Culper Research <a href="https://www.benzinga.com//node/40943334" target="_blank" rel="noreferrer noopener">issued a short report on the company</a>.</li>
<li>BioMarin Pharmaceutical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) stock lost 16.74% last week <a href="https://www.benzinga.com//node/40885653" target="_blank" rel="noreferrer noopener">following strong dwarfism drug data</a> from rival Ascendis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>).</li>
<li>Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) lost 13.26% <a href="https://www.benzinga.com//node/40961732" target="_blank" rel="noreferrer noopener">last week</a>.</li>
<li>FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) stock fell 11.08% after the company reported worse-than-expected Q1 financial results and <a href="https://www.benzinga.com//node/40948046" target="_blank" rel="noreferrer noopener">cut FY25 guidance</a>.</li>
<li>BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) stock decreased 9.01%. Pfizer, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and BioNTech received positive CHMP opinion for omicron KP.2-adapted <a href="https://www.benzinga.com//node/40956192" target="_blank" rel="noreferrer noopener">COVID-19 vaccine in the European Union</a>.</li>
<li>Arthur J. Gallagher &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) stock fell 7.17%. Several analysts raised <a href="https://www.benzinga.com/quote/ajg/analyst-ratings" target="_blank" rel="noreferrer noopener">the price target on the stock</a>.</li>
<li>Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) shares declined 6.97% after the company announced a selling stockholder&#8217;s public offering of shares <a href="https://www.benzinga.com//node/40949015" target="_blank" rel="noreferrer noopener">and a concurrent share repurchase</a>.</li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) stock fell 6.93% after <a href="https://www.benzinga.com//node/40961934" target="_blank" rel="noreferrer noopener">headline results from the mid-stage study</a> of monlunabant in obese patients.</li>
<li>Murphy USA Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUSA#NYSE">MUSA</a>) shares fell 6.90% after JP Morgan downgraded the stock from Neutral to Underweight but raised its <a href="https://www.benzinga.com/quote/musa/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $415 to $435</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972008/constellation-energy-li-auto-and-carvana-are-among-top-11-large-cap-gainers-last-week-sept-16-sept" target="_blank" rel="noreferrer noopener">Constellation Energy, Li Auto And Carvana Are Among Top 11 Large Cap Gainers Last Week (Sept 16-Sept 20): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Large Cap

BMRN

BNTX

CHWY

KSPI

MUSA

RIVN

SMMT

Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

Many people in their 20s deal with credit card debt or student loans, sometimes thinking they'll figure it out later. But what happens when that debt piles up to nearly a million dollars? That's the reality a 29-year-old named Channing from Washington D.C. faced during an episode of <a href="https://www.benzinga.com/personal-finance/24/09/40838359/dave-ramsey-says-youre-wasting-5-000-a-year-if-you-spend-13-70-a-day-on-things-you-dont-need">The Dave Ramsey Show.</a>
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
</ul>
Channing and her husband were grappling with nearly $1 million in debt, a number that had Ramsey quickly diving into tough-love mode. Sure, he's seen scenarios where people are in over their heads with debt, but at just 29, this was particularly alarming to Ramsey.&nbsp;
Channing, who recently married, explained, "My husband and I have probably just under a million dollars in debt and we want to know how to get debt-free without filing for bankruptcy." The breakdown included <a href="https://www.benzinga.com/personal-finance/24/08/40420920/we-have-the-highest-credit-card-debt-in-the-history-of-earth-says-grant-cardone-america-needs-to">$335,000 in student loans</a>, $136,000 in credit cards and $44,000 in personal loans. Their combined household income was about $230,000 a year.
Trending: Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a>
Ramsey didn't hold back. After calculating the staggering numbers, he addressed the couple's situation bluntly. "You guys have been living at about 10x where you're going to get to live for the next three years," Ramsey said. "I'm getting ready to destroy your life as you know it."
"You've gotten used to spending like you&#8217;re in Congress," he scolded. He was clear that their lifestyle needed a complete overhaul. Ramsey emphasized that their financial habits would have to change drastically, stating, "You're not gonna see the inside of a restaurant unless it's your extra job or you're waiting on someone you work with during the day." He added, "You're gonna be living on beans and rice, rice and beans."
See Also: <a href="https://www.benzinga.com/money/charlie-munger-100k">Charlie Munger said if you want to be rich, &#8220;find a way to get your hands on $100,000&#8221; — here&#8217;s what he means.</a>
Ramsey went on to stress the emotional and spiritual challenges ahead. "Your friends are going to think you've lost your mind and your mother is going to think you need counseling," he warned, adding that both Channing and her husband would need to stop caring what others think if they wanted to tackle their debt successfully.
He also shared a <a href="https://www.benzinga.com/personal-finance/24/03/37588475/dave-ramsey-shares-he-went-bankrupt-and-lost-everything-years-ago-while-empathizing-with-caller-">personal connection to their situation</a>, saying, "This is exactly what I did in my 20s. I bought and purchased a lifestyle that was 5x to 10x what I had. It was all because of crap inside of me that caused me to do that."
Trending: Elon Musk&#8217;s secret mansion in Austin revealed through court filings.<a href="https://www.benzinga.com/money/elon-musk-secret-mansion-austin-nada"> Here&#8217;s how to invest in the city&#8217;s growth before prices go back up.</a>
Ramsey's advice wasn't just about cutting expenses but about confronting the mindset that had led to their financial missteps. "The problem is what's going on inside you guys," Ramsey said. "You're on a suicide mission right now."
The tough conversation ended on a hopeful note, though. Ramsey assured Channing that while the journey would be difficult, it was possible. "You can do it, though," he said. "I know. I'll help you."
Channing and her husband are now facing a major lifestyle change to climb out of their nearly $1 million debt, with Dave Ramsey's guidance <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">pointing them toward a more financially stable future</a>. Sometimes debt happens, but at least they're taking steps to address the issue and make changes before they're left resorting to more extreme options such as bankruptcy.
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a></li>
</ul>

Personal Finance

Dave Ramsey Tells 29-Year-Old $1M In Debt And Spending Like She's In Congress: 'I'm Getting Ready To Destroy Your Life As You Know It'

Elon Musk, the billionaire who runs ventures such as Tesla, SpaceX and Neuralink, is a polarizing figure. The billionaire recently <a href="https://www.benzinga.com/news/24/09/40968413/elon-musk-reacts-after-cathie-wood-labels-gavin-newsoms-threat-to-sue-tesla-ceo-over-memes-unconstit">earned the wrath of California Gov. Gavin Newsom </a>over artificial intelligence political deepfake videos shared on X social-media platform but has received commendation from a congressman from the state.
Amazing Company: Rep. Kevin Kiley (R-Calif.) applauded Musk&#8217;s SpaceX for its Polaris Dawn mission in a speech at the House and also voiced concerns regarding the regulatory clampdown on the company, a video clip of the speech shared by an X platform user <a href="https://x.com/DimaZeniuk/status/1837599107327619318">showed.</a>
Polaris Dawn, a private crewed spaceflight&nbsp;operated by&nbsp;SpaceX&nbsp;on behalf of&nbsp;Shift4&nbsp;CEO&nbsp;Jared Isaacman, was launched on Sept. 10. Isaacman and his crew of three, namely Scott Poteet,&nbsp;Sarah Gillis&nbsp;and&nbsp;Anna Menon, flew in an&nbsp;elliptic orbit&nbsp;that took them 1,400 kilometers away from Earth, the farthest anyone has been since NASA&#8217;s&nbsp;Apollo program. The crew also performed the first commercial spacewalk. 
Talking about SpaceX, Kiley said it was started in California and that he had the opportunity to tour its facility a few years back. It truly is an amazing company and is vital to the U.S.&#8217; leadership when it pertains to space and is also vital to the national security, he said. He also noted that NASA is now relying on SpaceX to bring home <a href="https://www.benzinga.com/markets/equities/24/08/40541938/nasa-chooses-spacex-over-boeing-for-stranded-astronauts-return-starliners-future-in-doubt">two of its astronauts who are stranded at the International Space Station.</a>
See Also: <a href="https://www.benzinga.com/money/how-to-invest-in-spacex">How To Invest In SpaceX</a>
Government&#8217;s Vindictiveness: Despite SpaceX being a tremendous asset, the company is being targeted in multiple ways and for frivolous reasons, Kiley said. He noted that the Federal Aviation Administration recently fined $633,000 for trivial non-safety related reasons.
The federal agency has delayed flight five of Starship for two months, also for non-safety related reasons, he said, adding that roadblocks are being thrown in its way.
&#8220;We continue to be stuck in the reality where it takes longer to do the government paperwork to license a rocket launch than it does to design and build the actual hardware,&#8221; Kiley said. &#8220;There simply should not be delays related to paperwork or bureaucracy; The FAA and related agencies need to prioritize enabling launches and not standing in their way.&#8221;
Responding to the Congressman&#8217;s speech, Musk said it is &#8220;much appreciated.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Much appreciated
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1837704322622099748?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
 Why It&#8217;s Important: Musk has endorsed former President Donald Trump in the 2024 election, likely warded off by the Biden administration&#8217;s failure to acknowledge Tesla as the leader in green energy vehicle manufacturing, the Democratic party&#8217;s failure to control infiltration of undocumented immigrants and the party&#8217;s leftist agenda.
Recently, Newsom criticized Musk for sharing a deepfake video on Vice President Kamala Harris, who is the Democratic Party&#8217;s nominee, on X. The governor has now signed a law, banning the use of AI-generated deepfakes in political campaigns.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40951122/elon-musk-blasts-faa-for-targeting-spacex-over-petty-matters-while-ignoring-boeings-safety-issue">Elon Musk Blasts FAA For Targeting SpaceX Over &#8216;Petty Matters,&#8217; While Ignoring Boeing&#8217;s Safety Issues: This &#8216;Puts Human Lives At Risk&#8217;</a></li>
</ul>

Government

Elon Musk Responds As California Congressman Slams Bureaucratic Roadblocks For SpaceX Program: 'Agencies Need To Prioritize Enabling Launches And Not Standing In Their Way'

Billionaire investor Warren Buffett, <a href="https://www.benzinga.com/general/24/01/36763638/warren-buffett-accumulated-99-of-his-net-worth-after-turning-50-and-didnt-become-a-billionaire-until">who has tasted huge success in the investment world</a>, has a philosophical take on what defines success. His take on success and his success mantra are worth emulating to keep anyone on an even keel.
Buffet&#8217;s Take On True Success: If you get to be 65 years, or 70 years and later, and the people that you want to love you actually love you, you are a success, <a href="https://www.youtube.com/watch?v=Tr6MMsoWAog">said</a> Buffett in an interview with Yahoo Finance in 2019.
He also made the point that he has seen very, very wealthy people, so wealthy that they give testimonial interviews to, and name schools after, and everything, but they&#8217;re miserable. Nobody loves them, he added.
Buffett has often stressed that money doesn&#8217;t buy happiness and he lives out this philosophy by living a relatively modest lifestyle. In the Forbes billionaires list, he is in the sixth place, boasting of $143.7 billion in wealth. He is also known for his charity, having pledged 99% of his wealth to philanthropy&nbsp;during his lifetime or at death.&nbsp;
See Also: <a href="https://www.benzinga.com/markets/equities/24/09/40917216/elon-musk-says-warren-buffett-is-positioning-for-kamala-harris-win-with-his-277b-cash-pile-as-pr">Elon Musk Says Warren Buffett Is Positioning For Kamala Harris Win With His $277B Cash Pile As Pro-Trumper John Paulson Warns Of Equity Market Exit</a>
How To Succeed In Life: When the investment guru was asked to give advice as to how to succeed in life, he said by far the best investment one can make is in oneself. Buffett said he used to advise students that if they learned to communicate better, both orally and written, they can increase their value at least by 50%.
One has to be able to get their ideas across, he said, adding that acquiring it is easy. He noted that he took a Dale Carnegie course for it.
&#8220;If you invest in yourself nobody can take it away from you I mean you and the second thing,&#8221; Buffett said.
Secondly he said one should take care of their mind and body. &#8220;You get exactly one mind and one body in this world. And you can&#8217;t start taking care of it when you&#8217;re 50,&#8221; he said.&nbsp;
A life advice he gave out was to associate with people that are better than you. &#8220;You will go in the direction of the people that you associate with and you want to have the right heroes,&#8221; he said, adding that if you want to emulate somebody better, you better pick very carefully whom you want to emulate.
Buffett said of the people who you admire, who you want to copy and the most important for most people is their spouse. &#8220;You&#8217;ll want to pick a spouse that&#8217;s a little better than you,&#8221; he said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/best-value-stocks">Best Value Stocks</a></li>
</ul>

Psychology

Warren Buffett's Definition Of Success Has Nothing To Do With Wealth But About These 2 Things: Here's Why Ultra-Rich Are Often Miserable

This week, the Federal Reserve&#8216;s decision to reduce interest rates by 50 basis points boosted share prices across the technology, construction, <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40937291/bank-stocks-hit-inflection-point-after-feds-50-basis-point-cut-analyst-reveal-top-p" rel="noreferrer noopener">industrial, machinery, and financial sectors</a>.
These eleven large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) stock jumped 30.11% last week after <a href="https://www.benzinga.com//node/40957437" target="_blank" rel="noreferrer noopener">signing a 20-year power purchase agreement</a> with Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) to help launch the Crance Clean Energy Center and restart Three Mile Island Unit 1.</li>
<li>Vistra Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) stock gained 26.10% last week after <a href="https://www.benzinga.com//node/40943063" target="_blank" rel="noreferrer noopener">the company executed definitive agreements</a> with affiliates of Nuveen Asset Management and Avenue Capital Management II to acquire their combined 15% equity interest in Vistra Vision.</li>
<li>Carvana Co.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) shares increased 22.52%. Evercore ISI raised its price forecast <a href="https://www.benzinga.com/quote/CVNA/analyst-ratings" target="_blank" rel="noreferrer noopener">on the stock from&nbsp;$142&nbsp;to&nbsp;$157</a>.</li>
<li>Symbotic Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) stock gained 19.06% last week as stocks in the broader industrial space jumped following the Fed&#8217;s announcement to cut rates by 50 basis points, which could support investment and economic growth.</li>
<li>Duolingo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) stock was up 17.32% in the last week.</li>
<li>James Hardie Industries plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHX#NYSE">JHX</a>) stock upped 16.38% as stocks in the broader industrial space jumped following the Fed&#8217;s announcement to cut rates by 50 basis points, which could support investment and economic growth. The company also announced it has repurchased up to 8.4 million of its shares.</li>
<li>Texas Pacific Land Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>) gained 15.73% as stocks of oil and gas companies soared amid a rise in the price of oil after the Fed rate cut, which could lift the demand outlook.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) stock gained 15.71% as <a href="https://www.benzinga.com/quote/crwd/analyst-ratings" target="_blank" rel="noreferrer noopener">several analysts</a> maintained their buy forecasts and said the customer backlash following the software incident had largely passed.</li>
<li>Maplebear Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) shares rose 13.92%</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) stock jumped 13.47%&nbsp;last week after Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) assured investors it would not drop its majority stake in the <a href="https://www.benzinga.com//node/40949356" target="_blank" rel="noreferrer noopener">Israeli autonomous driving company</a>.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) <a href="https://www.benzinga.com//node/40946478" target="_blank" rel="noreferrer noopener">stock rose 12.66%</a>. Stocks of several U.S.-listed Chinese companies gained ahead of expectations that the People&#8217;s Bank of China will cut rates.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40972060/novo-nordisk-chewy-and-fedex-are-among-top-10-large-cap-losers-last-week-sept-15-sept-21-are-the-o" target="_blank" rel="noreferrer noopener">Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?</a></li>
</ul>
Photo by Ihor Bondarenko on Shutterstock

CART

CRWD

CVNA

DUOL

INTC

MBLY

Constellation Energy, Li Auto And Carvana Are Among Top 11 Large Cap Gainers Last Week (Sept 16-Sept 20): Are The Others In Your Portfolio?

In a Saturday X exchange with venture capitalist Vinod Khosla, Elon Musk explained <a href="https://www.benzinga.com/news/24/08/40145805/elon-musk-says-his-endorsement-of-trump-doesnt-mean-he-agrees-with-everything-ex-president-is-saying">his reason for endorsing Donald Trump in the 2024 race</a>.
Pro- Biden In 2020: Unlike Trump and his team, Musk doesn&#8217;t think the 2020 election wasn&#8217;t stolen. Musk had a different explanation for the Democratic Party&#8217;s win. &#8220;All the independent voters I know, myself included, leaned towards [Joe] Biden, thinking he would be a milquetoast moderate. Boring, but moderate,&#8221; he said.
Incidentally, Khosla also identified himself as an independent. &#8220;Remember I am an independent, not a democrat or a republican. There are democrats, independents, republicans and then there are a&#x2A;&#x2A;hole MAGA extremists,&#8221; he had said.
See Also: <a href="https://www.benzinga.com/markets/equities/24/09/40917216/elon-musk-says-warren-buffett-is-positioning-for-kamala-harris-win-with-his-277b-cash-pile-as-pr">Elon Musk Says Warren Buffett Is Positioning For Kamala Harris Win With His $277B Cash Pile As Pro-Trumper John Paulson Warns Of Equity Market Exit</a>
What&#8217;s Has Changed: Explaining why he changed side this time around, Musk said Biden turned out to be a &#8220;radical leftist puppet of the machine who loves overreaching bureaucracy, just like Kamala [Harris].&#8221;
That&#8217;s why Musk and almost all independent voters he knew were supporting Trump this time, he said.
Taking a potshot at Khosla, Musk said, &#8220;Now, you stop being a damn hypocrite and have some empathy for small towns throughout America getting swamped by 10,000+ poorly vetted migrants. It's not right.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">No, I don't think 2020 was stolen, as all the independent voters I know, myself included, leaned towards Biden, thinking he would be a milquetoast moderate. Boring, but moderate. Unfortunately, he turned out to be a radical leftist puppet of the machine who loves overreaching…
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1837634071289069730?ref_src=twsrc%5Etfw">September 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Replying to him, the Sun Microsystems co-founder said, &#8220;I have to agree that Biden&#8217;s treatment of Tesla as the EV leader was unfair so I understand your ire towards him.&#8221; It is a known secret that the Biden administration <a href="https://www.benzinga.com/government/23/12/36378996/elon-musks-yuletide-grudge-tesla-ceo-still-cross-with-biden-for-giving-cold-shoulder-2-years-ago">valued General Motors and Ford over Tesla</a> as flagbearers of the U.S. electric vehicle revolution. 
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year.&nbsp;<a href="https://www.benzinga.com/gov-trades" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>

Elon Musk Says Biden Belied His 2020 Expectations And Turned Out To Be A 'Radical Leftist Puppet': Why Billionaire Is Supporting Trump This Time Around

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of MedTech stocks. According to a McKinsey &amp; Company report, over the next five years, the industry may see the <a href="https://www.mckinsey.com/industries/life-sciences/our-insights/what-to-expect-from-medtech-in-2024#:~:text=Going%20into%202024%2C%20we%20expect,among%20the%20fastest%2Dgrowing%20segments.">fastest growth</a> in the realms of cardiovascular health, digital healthcare and robotics.



Overall, the MedTech ecosystem <a href="https://www.futuremarketinsights.com/reports/medtech-market">reached a valuation of $503.2 billion last year</a>, per Future Market Insights. By 2033, the sector could be worth nearly $776.5 billion. If so, the expansion would imply a compound annual growth rate (CAGR) of 4.4%. Fundamentally, chronic conditions such as diabetes, cardiovascular disease and obesity are on the rise globally. Therefore, MedTech stocks will likely benefit from burgeoning relevance.



While it may be tempting to view the medical innovation space cynically, we should also note that chronic disease imposes a collective economic impact. Therefore, these MedTech stocks offer a win-win for everyone.



<h2>Johnson &amp; Johnson (JNJ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/jnj1600-300x169.jpg" alt="Negative Press Presents a Buying Opportunity with JNJ Stock"><div>Source: Sundry Photography / Shutterstock.com</div></div>A global healthcare juggernaut, Johnson &amp; Johnson (NYSE:<a href="https://investorplace.com/stock-quotes/jnj-stock-quote/">JNJ</a>) focuses on two primary segments after spinning off its consumer health productions division: pharmaceuticals and medical devices. The latter segment covers areas such as orthopedics, surgery, interventional solutions and vision care. As a top-tier name in MedTech stocks, J&amp;J benefits from its brand footprint and generally predictable revenue streams.



Financially, the company probably wouldn&rsquo;t be classified as remarkable. However, what investors should appreciate is that it gets the job done. In the past year since the second quarter, J&amp;J posted an average earnings per share of $2.62. That&rsquo;s above the collective consensus estimate over the period of $2.54, yielding an earnings surprise of 3.28%.



To be fair, JNJ stock isn&rsquo;t cheap, <a href="https://finance.yahoo.com/quote/JNJ/key-statistics/">trading hands at 4.5X trailing-year sales</a>. However, it&rsquo;s a modest premium over the past year&rsquo;s average metric of 4.39X. Further, analysts see slow and steady expansion of the business over the next two years. By the end of fiscal 2025, <a href="https://finance.yahoo.com/quote/JNJ/analysis/">EPS could be $10.71 on revenue of $91.11 billion</a>. Last year, these metrics sat at $9.92 on $85.16 billion.



<h2>Abbott Laboratories (ABT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/abt1600-300x169.jpg" alt="Abbott (ABT) sign with lighting behind letters"><div>Source: testing / Shutterstock.com</div></div>A diversified healthcare enterprise, Abbott Laboratories (NYSE:<a href="https://investorplace.com/stock-quotes/abt-stock-quote/">ABT</a>) features solutions in diagnostics, nutrition, pharmaceuticals and medical devices. It&rsquo;s one of the most popular names among MedTech stocks thanks to its vast product portfolio, particularly for cardiovascular and diabetes care. Notably, its FreeStyle Libre brand of continuous glucose monitoring systems make Abbott a key player in managing chronic conditions.



As with Johnson &amp; Johnson above, Abbott doesn&rsquo;t particularly generate impressive financials. However, it&rsquo;s a reliable entity. In the past year since Q2, the company posted an average EPS of $1.11. This figure pipped the consensus view by two pennies, yielding an <a href="https://finance.yahoo.com/quote/ABT/analysis/">earnings surprise of 2.6%</a>.



ABT stock isn&rsquo;t super pricey in terms of valuation but it&rsquo;s not cheap. Right now, shares trade at 4.5X sales. However, the market previously accepted a revenue multiple of 4.54X. In that sense, Abbott appears fairly valued.



Looking out to year&rsquo;s end, analysts see EPS rising by 5% to $4.66. On the top line, sales could see a 4.1% lift to $41.74 billion. Add in a 2.1% forward yield and you have the makings of one of the top MedTech stocks.



<h2>Edwards Lifesciences (EW)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/health-medical-heart-1600-300x169.jpg" alt="hands holding a red heart shape against blue background symbolizing health"><div>Source: shutterstock.com/Anastasia Zagoruyko</div></div>Billed as a specialist in the field for addressing structural heart diseases, Edwards Lifesciences (NYSE:<a href="https://investorplace.com/stock-quotes/ew-stock-quote/">EW</a>) focuses on developing heart valve replacement technologies and critical care monitoring systems. The company stands at the forefront of cardiovascular innovation. In particular, its minimally invasive heart valve replacement solution offers a literal lifeline for patients.



Financially, it must be stated that Edwards isn&rsquo;t as impressive as other major MedTech stocks. In Q3 and Q4 of last year, the company only met <a href="https://finance.yahoo.com/quote/EW/analysis/">earnings expectations</a>. However, it did beat bottom-line targets in the subsequent two quarters. Overall, the average EPS came out to 65 cents, beating the consensus average of 64 cents.



Another factor to consider is the higher premium. Presently, EW stock trades at 6.72X trailing-year sales. While elevated among peers, the market previously accepted a multiple of 9.09X in the past year.



Notably, analysts are looking at EPS expansion of almost 8% to $2.70 by year&rsquo;s end. Also, the top line could rise to $6.39 billion, up 6.4%.



<h2>Glaukos (GKOS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/12/eye-1600-300x169.jpg" alt="A close-up of someone's eye"><div>Source: Shutterstock</div></div>An ophthalmic pharmaceutical enterprise, Glaukos (NYSE:<a href="https://investorplace.com/stock-quotes/gkos-stock-quote/">GKOS</a>) develops devices and therapeutics for the treatment of glaucoma, corneal disorders and retinal diseases. To note, Glaukos is one of the pioneers in the field of micro-invasive glaucoma surgery or MIGS. Its innovative approach combined with certain less-invasive treatment options make GKOS an attractive idea for MedTech stocks.



Glaukos represents one of the riskier ideas in the sector. For one thing, it&rsquo;s not profitable. Moreover, in the past year since Q1 2024, the company incurred a loss per share of 60 cents. That&rsquo;s worse than the anticipated 56 cents in the red, yielding a negative &ldquo;earnings&rdquo; surprise of 7%.



Also, the price-to-sales ratio of nearly 18X may be tough to swallow. It&rsquo;s also up from the prior year&rsquo;s average metric of 11.9X. So, why bother with GKOS stock?



Analysts are looking for <a href="https://finance.yahoo.com/quote/GKOS/analysis/">robust growth</a> in the years ahead. By the end of fiscal 2025, sales could hit $451.62 million. That&rsquo;s up significantly from last year&rsquo;s print of $314.71 million. For speculators, Glaukos could rank among the MedTech stocks to gamble on.



<h2>Inari Medical (NARI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/red-blood-cells-1600-300x169.png" alt="Red blood cells."><div>Source: Corona Borealis Studio / Shutterstock</div></div>Based in Irvine, California, Inari Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/nari-stock-quote/">NARI</a>) develops minimally invasive catheter-based devices to treat venous diseases. These include blood clots and deep vein thrombosis. One of the company&rsquo;s mainline products is called LimFlow, which is designed for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical options.



Another higher-risk, higher-reward idea among MedTech stocks, Inari lacks consistent profitability. It posted great results in Q2 and Q3 of last year. However, the subsequent two quarters have been messy. Overall, the average loss per share in the past four quarters came out to 5 cents. However, experts were anticipating a loss of 8 cents per share.



On the top line, Inari is a bit pricey for a MedTech player, trading hands at 5.89X sales. That said, in the past year this metric stood at 7.54X. It&rsquo;s conceivable that NARI stock might rise to its prior valuation.



By the end of 2024, analysts are looking for revenue of $598.72 million. If so, that would imply a growth rate of 21.3%, making NARI an intriguing idea for MedTech stocks to buy.



<h2>iRhythm Technologies (IRTC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/love-heart-stock-money-300x169.png" alt="Stacks of gold coins increasing in amount lead up to a big red heart"><div>Source: Shutterstock</div></div>A digital healthcare company, iRhythm Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/irtc-stock-quote/">IRTC</a>) engages in the design, development and commercialization of device-based tech. These solutions provide ambulatory cardiac monitoring services to diagnose arrhythmias. The company is known for its Zio Monitor patch, which offers a more convenient and comprehensive mechanism to detect arrhythmias.



Moving into an even riskier space for the possibility of greater rewards, iRhythm isn&rsquo;t a profitable company. Indeed, during the past four quarters, the MedTech specialist incurred a loss per share of $1. That was conspicuously worse than the expected red ink of 74 cents, yielding a negative surprise of 35%.



To be sure, IRTC stock isn&rsquo;t a screaming deal either in the revenue front, trading at 5.3X sales. However, in the past year, this metric stood at 7.34X. Again, it&rsquo;s possible that with some positive catalyst, IRTC may rise to its former valuation.



Analysts are hoping for exactly that, with fiscal 2024 sales <a href="https://finance.yahoo.com/quote/IRTC/analysis/">possibly landing at $583.5 million</a>. That would be up 18.4% from the prior year&rsquo;s tally of $492.68 million. It&rsquo;s one of the MedTech stocks to consider if you&rsquo;re the gambling type.



<h2>SI-Bone (SIBN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/hospital1600-300x169.jpg" alt="Image of a hospital with workers walking in the halls"><div>Source: Shutterstock</div></div>A medical device firm that operates in the field of musculoskeletal disorders, SI-Bone (NASDAQ:<a href="https://investorplace.com/stock-quotes/sibn-stock-quote/">SIBN</a>) is relevant but also highly speculative. As one of the smaller MedTech stocks available, SIBN&rsquo;s price action is subject to extreme volatility. That said, the fundamentals are compelling. SI-Bone offers minimally invasive surgical implants for the treatment of sacroiliac joint dysfunction.



As you might imagine, SI-Bone has difficulty with the profitability department. In the past four quarters, the company posted an average loss per share of 27 cents. Still, analysts anticipated during this time that the average loss would land at 33 cents. So, technically speaking, the average surprise came out to 18%.



Regarding sales, SIBN trades at 4.19X revenue. That&rsquo;s not terrible but it&rsquo;s not great by any means. However, in the past year, the metric stood at loftier 6.15X. Under the right conditions, SI-Bone could rise to its former valuation.



Analysts are aiming for such a reality to materialize, broadcasting a <a href="https://finance.yahoo.com/quote/SIBN/analysis/">sales target of $165.05 million</a> by year&rsquo;s end. That&rsquo;s up 18.8% from the prior year. In the following year, revenue could pop again to $191.54 million, potentially enticing market gamblers.



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/07/7-leading-medtech-stocks-for-next-gen-health-solutions/">7 Leading MedTech Stocks for Next-Gen Health Solutions</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Leading MedTech Stocks for Next-Gen Health Solutions

Inari Medical (NARI – Research Report) received a Buy rating and a $68.00 price target from Deutsche Bank analyst Pito Chickering today. The compan...

Inari Medical (NARI) Receives a New Rating from Deutsche Bank

Penumbra Grinding Through A Painful Growth Expectations Reset

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inari Medical (NARI – Research Report) and PROCEPT B...

Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI) and PROCEPT BioRobotics (PRCT)

Kallum Titchmarsh, an analyst from Morgan Stanley, maintained the Buy rating on Inari Medical (NARI – Research Report). The associated price target...

Inari Medical's Resilience and Market Potential Affirm Buy Rating

Mike Kratky, an analyst from Leerink Partners, has initiated a new Hold rating on Inari Medical (NARI). Mike Kratky's rating is based on the dynami...

Inari Medical: Navigating Competitive Threats and Growth Potential in Venous Thromboembolism Treatment

Morgan Stanley analyst Kallum Titchmarsh has maintained their bullish stance on NARI stock, giving a Buy rating on August 28. Kallum Titchmarsh has...

Inari Medical: A Strong Buy on Robust Product Reception and Promising Financial Outlook

In a report released on September 6, Larry Biegelsen from Wells Fargo assigned a Buy rating on Inari Medical (NARI – Research Report), with a price...

Inari Medical: Strong Buy Rating Amidst Anticipated Growth Catalysts and Market Expansion

In a report released today, Adam Maeder from Piper Sandler maintained a Hold rating on Inari Medical (NARI – Research Report), with a price target ...

Piper Sandler Keeps Their Hold Rating on Inari Medical (NARI)

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Inari Medical (NARI – Research Report) yesterday and set a price target of $65.00. L...

Buy Rating for Inari Medical Amid Positive PEERLESS Trial Outlook and Revenue Growth Potential

GKOS

IRTC

PRCT

SIBN

Legal

Press Releases

NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. – NARI

Inari Medical to Announce Second Quarter 2024 Financial Results

Inari Medical Reports Second Quarter 2024 Financial Results

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

Inari Medical to Present at Upcoming Investor Conferences

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm

Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the Firm

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Inari Medical

Inari Medical (NARI) Forecast

Inari Medical (NASDAQ:NARI) Stock, Quote.Headers.trade-ideas